<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Increases in plasma plant sterols stabilize within four weeks of plant sterol intake and are independent of cholesterol metabolism</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-12">12 December 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Ras</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Koppenol</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">U</forename><surname>Garczarek</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Otten-Hofman</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Fuchs</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Wagner</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Charité Research Organisation</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Unilever Research and Development Vlaardingen</orgName>
								<address>
									<settlement>Vlaardingen</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Italian Society of Human Nutrition</orgName>
								<orgName type="department" key="dep2">Department of Clinical Medicine and Surgery</orgName>
								<orgName type="institution">Feder-ico II University</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Unilever R&amp;D Vlaardingen</orgName>
								<address>
									<addrLine>Olivier van Noortlaan 120</addrLine>
									<postBox>P.O. Box 114</postBox>
									<postCode>3130 AC</postCode>
									<settlement>Vlaardingen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Clinical Medicine and Surgery</orgName>
								<orgName type="institution" key="instit1">the Italian Society of Human Nutrition</orgName>
								<orgName type="institution" key="instit2">Federico II University</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Increases in plasma plant sterols stabilize within four weeks of plant sterol intake and are independent of cholesterol metabolism</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-12">12 December 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">7C1D28E9E91A11EB5067B3F714A81AA9</idno>
					<idno type="DOI">10.1016/j.numecd.2015.11.007</idno>
					<note type="submission">Received 26 August 2015; received in revised form 19 October 2015; accepted 13 November 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Plant sterols</term>
					<term>Cholesterol</term>
					<term>Time curves</term>
					<term>Absorption</term>
					<term>Synthesis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background and aims: Plant sterols (PS) lower plasma LDL-cholesterol through partial inhibition of intestinal cholesterol absorption.</s><s>Although PS themselves are poorly absorbed, increased intakes of PS result in elevated plasma concentrations.</s><s>In this paper, we report time curves of changes in plasma PS during 12 weeks of PS intake.</s><s>Furthermore, the impact of cholesterol synthesis and absorption on changes in plasma PS is explored.</s><s>Methods and results: The study was a double-blind, randomized, placebo-controlled, parallelgroup study with the main aim to investigate the effects of PS on vascular function (clinicaltrials.gov:</s><s>NCT01803178).</s><s>Hypercholesterolemic but otherwise healthy men and women (n Z 240) consumed low-fat spreads without or with added PS (3 g/d) for 12 weeks after a 4week run-in period.</s><s>Blood sampling was performed at week 0, 4, 8 and 12. Basal cholesterolstandardized concentrations of lathosterol and sitosterol þ campesterol were used as markers of cholesterol synthesis and absorption, respectively.</s><s>In the PS group, plasma sitosterol and campesterol concentrations increased within the first 4 weeks of intervention by 69% (95%CI: 58; 82) starting at 7.2 mmol/L and by 28% (95%CI: 19; 39) starting at 11.4 mmol/L, respectively, and remained stable during the following 8 weeks.</s><s>Placebo-corrected increases in plasma PS were not significantly different between high and low cholesterol synthesizers (P-values &gt;0.05).</s><s>Between high and low cholesterol absorbers, no significant differences were observed, except for the cholesterol-standardized sum of four major plasma PS (sitosterol, campesterol, brassicasterol  and stigmasterol)  showing larger increases in low absorbers (78.3% (95%CI: 51.7; 109.5))</s><s>compared to high absorbers (40.8% (95%CI: 19.9; 65.5)).</s><s>Conclusions: Increases in plasma PS stabilize within 4 weeks of PS intake and do not seem impacted by basal cholesterol synthesis or absorption efficiency.</s></p><p><s>This study was registered at clinicaltrials.gov</s><s>(NCT01803178).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Plant sterols (PS) are lipid-like compounds that occur naturally in small amounts in plant-based foods and in higher amounts in specific enriched foods.</s><s>Consumption of foods with added PS is effective in lowering total-, and especially, LDL-cholesterol concentrations <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>LDL-cholesterol is the most important blood lipid risk factor for coronary heart disease (CHD) <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s></p><p><s>PS inhibit intestinal cholesterol absorption <ref type="bibr" target="#b4">[5]</ref> through several hypothesized mechanisms such as competition with cholesterol for solubilization in dietary mixed micelles, interference with transport-mediated processes of cholesterol uptake and stimulation of cholesterol excretion via the intestine <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>The inhibition of intestinal cholesterol absorption with PS intake occurs rapidly and the maximal LDL-cholesterol lowering effect for a given dose of PS is usually achieved within the first 2e3 weeks of intake.</s><s>PS in contrast to cholesterol are poorly absorbed from the intestine.</s><s>In fact, due to active excretion of PS by the ABCG5/G88 transporters from the enterocytes back into the intestinal lumen and from the liver into the bile, net absorption of PS is less than 5% <ref type="bibr" target="#b7">[8]</ref>.</s><s>Consequently, circulating PS concentrations in humans are relatively low, i.e. w250 times lower compared to cholesterol <ref type="bibr" target="#b8">[9]</ref>.</s><s>Nevertheless, when intakes of PS are high, e.g. with intake of foods with added PS, plasma PS concentrations modestly increase <ref type="bibr" target="#b9">[10]</ref>.</s><s>It is not well established how rapidly plasma PS concentrations rise, and whether the increase in plasma PS will stabilize over time.</s><s>Additionally, some earlier studies have suggested that part of the variation in the LDL-cholesterol-lowering efficacy of PS is explained by endogenous factors of cholesterol metabolism such as cholesterol synthesis and/or absorption efficiency <ref type="bibr" target="#b10">[11]</ref>.</s><s>Whether cholesterol metabolism would also explain some of the variation in increases in plasma PS after PS-enriched food intake requires further investigation.</s></p><p><s>The primary result of this large randomized intervention study provided evidence that the regular intake of a low-fat spread with added PS (3 g/d) lowered total-and LDL-cholesterol whereas endothelial function as measured by flow-mediated dilation (FMD) was neither improved nor worsened <ref type="bibr" target="#b11">[12]</ref>.</s><s>No correlation was observed between changes in plasma PS and changes in FMD whereas a modest but significant correlation was observed between changes in LDL-cholesterol and changes in FMD <ref type="bibr" target="#b11">[12]</ref>.</s><s>In the current paper, we aimed to investigate the changes over time in plasma sitosterol and campesterol concentrations during 12 weeks of PS intake.</s><s>In addition, the PS-induced changes over time in total-and LDL-cholesterol were investigated.</s><s>Furthermore, we explored the impact of cholesterol metabolism, more specifically of cholesterol synthesis and absorption efficiency as determined by basal non-cholesterol sterols standardized for total cholesterol (TC), on the changes in plasma PS and serum lipids after PS intake.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>Hypercholesterolemic, but otherwise healthy, men and post-menopausal women were recruited among inhabitants of Berlin and surroundings through advertisements.</s><s>Individuals were selected based on the following main selection criteria: being apparently healthy; aged between 40 and 65 y; having LDL-cholesterol between 3.4 and 4.9 mmol/L; having a BMI between 18 and 30 kg/m 2 ; no occurrence of cardiovascular or systemic inflammatory diseases or diabetes mellitus; no use of lipid-lowering foods or drugs or other drugs that may interfere with the study outcomes; not smoking; and willing to comply with the study procedures.</s><s>Informed consent was obtained from all study participants.</s><s>The protocol was approved by the ethical committee of Charité Hospital and was conducted in accordance with the Helsinki declaration.</s><s>This study was registered at clinicaltrials.gov</s><s>(NCT01803178).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design and measurements</head><p><s>This study was designed as a double-blind, randomized, placebo-controlled, parallel-group intervention study.</s><s>Following a 4-week run-in period, study participants were randomized, after stratification for age, sex and screening LDL-cholesterol, across two treatment groups: 20 g/d of low-fat (w40% fat) spread with added PS esters (3 g/d, expressed in free PS equivalents) or 20 g/d of placebo spread (comparable in fat composition, taste and appearance).</s><s>Participants consumed two 10 g portion packs of spread daily.</s><s>Consumption was recorded in a diary and opened and unopened portion packs were counted to determine compliance.</s><s>The phytosterol mixture contained 70% sitosterol, 14% campesterol, 8% sitostanol, 3% brassicasterol, and some other phytosterols.</s><s>The intervention period lasted 12 weeks.</s><s>The spreads were produced by Unilever Research and Development Vlaardingen, The Netherlands.</s><s>Participants were instructed to consume their typical diet and minimize changes in their diet and lifestyle habits, to refrain from foods containing PS or other ingredients claiming to lower blood cholesterol and to avoid using concomitant medication or vasoactive substances that could interfere with the study outcomes.</s><s>Full details of this study were recently published <ref type="bibr" target="#b11">[12]</ref>.</s></p><p><s>Fasted blood samples were drawn at 4-week intervals (week 0, 4, 8 and 12) for measuring serum lipids by colorimetry on a Beckman Coulter AU analyzer (Synlab, Germany) and plasma non-cholesterol sterols by gas chromatography-mass spectrometry (GC-MS) with flame ionization detection (Unilever Research and Development Vlaardingen <ref type="bibr" target="#b12">[13]</ref>).</s><s>All samples of each subject were analyzed within the same assay.</s><s>Lathosterol at baseline was used as a marker of cholesterol synthesis whereas the sum of plasma sitosterol and campesterol at baseline was used as a marker of cholesterol absorption <ref type="bibr" target="#b13">[14]</ref>.</s><s>High or low cholesterol synthesizers and high or low cholesterol absorbers were defined using, as cut-offs, the genderspecific 25th and 75th percentiles of the basal lathosterol/TC ratio and the basal sitosterol þ campesterol/TC ratio, respectively.</s><s>Subjects with values between these percentiles were excluded for this particular analysis.</s><s>Noncholesterol to TC ratios were calculated using the cholesterol concentration as derived from the same GC-MS assay.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Statistical analysis was performed using the JMP application (version 11.0).</s><s>Data of participants that violated the protocol, as determined in a blind review process, were excluded <ref type="bibr" target="#b11">[12]</ref>.</s><s>Both absolute and TC-standardized noncholesterol sterol concentrations and the sum of the four major PS (sitosterol, campesterol, brassicasterol and stigmasterol) were analyzed.</s><s>Because most plasma noncholesterol sterols were not normally distributed, a log transformation was applied for all non-cholesterol sterols, after calculation of the ratios.</s><s>Triglycerides were also log transformed.</s><s>Log transformation resulted in normally distributed values appropriate for statistical analysis.</s><s>An ANCOVA was performed with the change from baseline as the outcome variable.</s><s>For the time curves, we established models based on repeated measurements including treatment, baseline value, visit (week 4, 8 and 12) and a treatment*visit interaction.</s><s>For the cholesterol synthesis/ absorption analysis, we established models based on the 12-week data including treatment, baseline value, group (high or low synthesizers/absorbers) and a treatment*group interaction.</s><s>For exploratory purposes, we repeated the latter analysis for men and women separately.</s><s>A P-value &lt;0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subject characteristics</head><p><s>In total, 240 subjects (150 men and 90 women) were enrolled into the study (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Eight subjects dropped out prematurely.</s><s>Six subjects violated the protocol (i.e.</s><s>not being weight stable) and were excluded from further analysis leaving maximally 226 subjects for the analysis.</s><s>The number of missing values in the plasma non-cholesterol sterol and serum lipid concentrations ranged from one to eight per variable.</s><s>Because we excluded subjects with basal a High or low cholesterol synthesizers and high or low cholesterol absorbers were defined using, as cut-offs, the gender-specific 25th and 75th percentiles of the basal lathosterol/TC ratio and the basal sitosterol þ campesterol/TC ratio, respectively.</s></p><p><s>b This n is the maximal number of subjects that has been included to calculate the means or medians of the variables listed; per variable, a few missings may have been present.</s></p><p><s>c Non-cholesterol sterols were standardized by using the total cholesterol (TC) value from the same GC-MS assay.</s></p><p><s>lathosterol/TC values (for the comparison between high and low synthesizers) and sitosterol þ campesterol/TC values (for the comparison between high and low absorbers) between the gender-specific 25th and 75th percentiles, only half of the available data were used to investigate the impact of cholesterol metabolism.</s><s>At the two intermediate blood sampling visits (week 4 and 8), plasma non-cholesterol sterols were only assessed in a subset of 100 subjects.</s><s>Taking into account a few missing values, repeated plasma sitosterol and campesterol concentrations were available for 95 subjects to investigate the impact of intervention duration.</s><s>By design, low synthesizers had lower lathosterol/TC concentrations (median value: 0.84 mmol/mmol) vs. high synthesizers (1.80 mmol/mmol) whereas low absorbers had lower sitosterol þ campesterol/TC concentrations (1.80 mmol/mmol) vs. high absorbers (4.37 mmol/mmol).</s><s>Compared to high cholesterol synthesizers, low synthesizers had significantly (P &lt; 0.05) lower body weight, BMI, triglycerides and desmosterol concentrations, and higher total-and HDL-cholesterol, sitosterol, campesterol, brassicasterol and sitostanol concentrations.</s><s>Compared to high cholesterol absorbers, low absorbers had significantly (P &lt; 0.05) higher BMI, triglycerides, lathosterol and desmosterol concentrations, and lower HDL-cholesterol, sitosterol, campesterol, brassicasterol, stigmasterol and sitostanol concentrations.</s><s>At baseline, the lathosterol/TC ratio was significantly, but modestly, inversely correlated with the sitosterol þ campesterol/TC ratio (R Z À0.5; P &lt; 0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact of intervention duration</head><p><s>During the 12-week intervention period, plasma sitosterol and campesterol concentrations were unaltered in the placebo group.</s><s>In the PS group, plasma sitosterol and campesterol concentrations were 7.2 and 11.4 mmol/L at baseline, respectively.</s><s>Within the first 4 weeks of intervention, they increased by 69% (95%CI: 58; 82) and by 28% (95%CI: 19; 39), respectively, but remained stable during the following 8 weeks (P-value treatment*visit for sitosterol Z 0.471 and P-value treatment*visit for campesterol Z 0.950) (Fig. <ref type="figure" target="#fig_0">1A and B</ref>).</s></p><p><s>The change from baseline in total-and LDL-cholesterol was significantly different at week 12 compared to weeks 4 and 8 (P-values visit &lt; 0.05; Fig. <ref type="figure" target="#fig_0">1C and D</ref>).</s><s>The largest reductions in total-and LDL-cholesterol concentrations were seen in the first 4 weeks in the PS group (À0.36 mmol/L (95%CI: À0.49; À0.23) and À0.33 (95%CI: À0.43; À0.24), respectively).</s><s>Concentrations stabilized between week 4 and week 8 in both groups and were further reduced in the PS group but also in the placebo group between week 8 and week 12.</s><s>In fact, LDLcholesterol was 0.19 mmol/L (95%CI: 0.05; 0.33) lower at week 12 vs.</s><s>week 8 in the placebo group and 0.14 mmol/L (95%CI: 0.01; 0.27) lower in the PS group.</s><s>Total cholesterol was 0.30 mmol/L (95%CI: 0.11; 0.49) lower at week 12 vs.</s><s>week 8 in the placebo group and 0.23 mmol/L (95%CI: 0.05; 0.42) lower in the PS group.</s><s>The interaction between treatment*visit was not significant (P-value treatment*visit for total cholesterol Z 0.871 and P-value treatment*visit for LDLcholesterol Z 0.895), implying that the time curves of total-and LDL-cholesterol were similar for individuals in both groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact of cholesterol synthesis and absorption efficiency</head><p><s>PS intake significantly increased concentrations of sitosterol, campesterol, brassicasterol and the sum of the four major PS (with and without standardization for TC) in both high and low cholesterol synthesizers.</s><s>Although increases in most plasma PS seemed larger in the high synthesizers, no significant differences in treatment effects between both groups were observed (P-values treatment*group &gt; 0.05; Table <ref type="table" target="#tab_1">2</ref>).</s><s>When stratifying the individuals into high and low cholesterol absorbers (Table <ref type="table" target="#tab_2">3</ref>), PS intake increased concentrations of sitosterol, campesterol, brassicasterol and the sum of the four major PS (with and without standardization for TC).</s><s>Again, the treatment*group interactions were not significant, except for the TCstandardized change in the sum of the four major PS (P-value treatment*group Z 0.043) and a borderline significant effect for the change in TC-standardized sitosterol (Pvalue treatment*group Z 0.052), both showing larger increases in low absorbers.</s><s>The lathosterol/TC ratio increased significantly by 16e18% after PS intake vs. placebo, reflecting an increased cholesterol synthesis rate with PS intake.</s></p><p><s>Serum total-and LDL-cholesterol were reduced in subgroups of low and high cholesterol synthesizers and absorbers after PS intake by 0.16e0.20 mmol/L and 0.19 mmol/L, respectively, but these effects were not statistically significant.</s><s>In the total study population (n Z 218), the reductions in total-and LDL-cholesterol (0.26 and 0.26 mmol/L, respectively) were significant as reported previously <ref type="bibr" target="#b11">[12]</ref>.</s><s>No impact of baseline cholesterol synthesis or absorption efficiency was observed on serum lipid concentrations.</s></p><p><s>When exploring the placebo-corrected changes from baseline in LDL-cholesterol and in the sum of plasma PS in the various cholesterol synthesis and absorption groups separately for men and women (Fig. <ref type="figure" target="#fig_1">2</ref>), we observed different effects in men and women when divided in groups based on the synthesis marker lathosterol/TC ratio.</s><s>Men with a low lathosterol/TC ratio at baseline seemed to have an enhanced LDL-cholesterol-lowering effect of PS compared to men with high lathosterol/TC ratio.</s><s>This observation seemed reversed in women.</s><s>Plasma PS increases were not differently affected by cholesterol synthesis and/or absorption markers in men and women, except for a higher increase in plasma PS in men with low vs. high sitosterol þ campesterol/TC ratio.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The current study shows that consumption of a low-fat spread with added PS increases plasma concentrations of sitosterol and campesterol (the two major PS in the formulation) in the first four weeks while no further increases were observed in the following eight weeks.</s><s>The placebo-corrected reductions in serum total-and LDL- cholesterol concentrations also occurred especially in the first four weeks of PS intake and remained stable thereafter.</s></p><p><s>The PS-induced changes in serum lipids and plasma noncholesterol sterols were not different between high and low cholesterol synthesizers (as defined by the lathosterol/TC ratio at baseline) or between high and low cholesterol absorbers (as defined by the sitosterol þ campesterol/TC ratio at baseline).</s></p><p><s>In the general population, campesterol concentrations range from 6.9 to 27.9 mmol/L, whereas sitosterol levels range from 2.8 to 16.0 mmol/L <ref type="bibr" target="#b8">[9]</ref>.</s><s>In our study, the concentrations at the end of the PS intervention increased up to on average 16 mmol/L for campesterol and 13 mmol/L for sitosterol, thus not exceeding physiological values.</s><s>Nevertheless, some concerns exist around elevated plasma PS concentrations after PS-enriched food intake.</s><s>Patients with homozygous phytosterolemia have very high plasma PS concentrations and often, but not always, experience early onset of atherosclerosis <ref type="bibr" target="#b14">[15]</ref>.</s><s>Furthermore, some observational studies suggested that moderately elevated plasma PS concentrations may be associated with increased CVD risk, but data is conflicting <ref type="bibr" target="#b15">[16]</ref>.</s><s>Although concentrations of plasma PS seen in homozygous phytosterolemic patients <ref type="bibr" target="#b9">[10]</ref> are 20e45 higher than the concentrations seen after PS-enriched food intake, and the association between plasma PS and CVD risk may be explained by plasma PS being a surrogate marker of intestinal cholesterol absorption, investigation into the impact of PS intake duration and cholesterol metabolism efficiency was judged relevant.</s></p><p><s>Studies that investigate the cholesterol-lowering effect of phytosterols often last for four weeks.</s><s>This time period is usually considered sufficient for blood cholesterol concentrations to reach a new steady state after a dietary intervention <ref type="bibr" target="#b16">[17]</ref>.</s><s>Indeed, our data show that, compared to placebo, total-and LDL-cholesterol were lowered at week 4, and were not further reduced at weeks 8 and 12, as also shown in other studies <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s>A surprising finding is, however, that total-and LDL-cholesterol dropped by w5% at week 12 vs.</s><s>weeks 4 and 8 in both the placebo group and in the intervention group.</s><s>It explained the observed 12-week changes from baseline in the placebo group of À0.34 mmol/L and À0.22 mmol/L in total-and LDLcholesterol, respectively, that we reported previously <ref type="bibr" target="#b11">[12]</ref>.</s><s>It could be that seasonal influences (i.e. the study ended in summer) or increased awareness of having elevated LDL-cholesterol have let to changes in the subjects' habits thereby unintendedly influencing their lipid levels halfway the study.</s></p><p><s>Our study is the first study that had repeated measurements of plasma PS within a 12 weeks timeframe after a daily intake of 3 g PS, which is the maximal intake recommendation.</s><s>We observed that plasma sitosterol and campesterol concentrations were similar after 4 weeks and after 8 and 12 weeks of intervention, confirming previously reported data for low doses of PS (&lt;0.5 g/d) <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s>Longer-term intervention studies (up to 85 weeks) have also shown that plasma PS do not further increase with sustained PS intake <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b22">23]</ref>.</s></p><p><s>The relationship between cholesterol synthesis and cholesterol absorption is suggested to be reciprocal <ref type="bibr" target="#b23">[24]</ref>; high synthesizers are usually low absorbers whereas low synthesizers are usually high absorbers.</s><s>Indeed, our analysis of the baseline data showed that those individuals with high lathosterol/TC ratios had significantly lower TCstandardized plasma PS concentrations compared to those with low lathosterol/TC ratios.</s><s>On the contrary, individuals with high vs. low sitosterol þ campesterol/TC ratios had lower TC-standardized lathosterol concentrations at baseline.</s><s>High synthesizers and low absorbers also had higher body weight, BMI, triglycerides, and lower HDLcholesterol, thus reflecting to some extent a metabolic syndrome population.</s></p><p><s>Based on earlier findings, we hypothesized that low cholesterol synthesis <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26]</ref> and high cholesterol absorption [26e29] would be associated with a larger cholesterol-lowering effect of PS intake.</s><s>We were not able to confirm such a potential influence of cholesterol metabolism efficiency on cholesterol-lowering efficacy.</s><s>Based on explorative analysis (Fig. <ref type="figure" target="#fig_1">2</ref>), there was however some indication that a larger cholesterol-lowering efficacy with PS intake in low vs. high synthesizers, as e.g.</s><s>observed in the study by MacKay et al. <ref type="bibr" target="#b10">[11]</ref>, may only been seen in men and not in women.</s><s>Further research is needed to investigate this potential interaction between treatment, cholesterol synthesis rate and sex.</s></p><p><s>Whether cholesterol synthesis and/or absorption efficiency would also explain some of the variation in increases in plasma PS after PS-enriched food intake has not frequently been studied.</s><s>One could hypothesize that individuals with high cholesterol absorption efficiency may hyperabsorb PS and show large elevations in plasma concentrations upon PS intake.</s><s>On the other hand, in individuals with low baseline plasma PS, there may be more room for plasma PS to increase after PS intake.</s><s>Houwelingen et al. <ref type="bibr" target="#b13">[14]</ref> found that plasma campesterol concentrations were more increased in individuals with low vs. high plasma PS at baseline, but this treatment by group interaction was not statistically significant.</s><s>We observed larger increases in plasma sitosterol and in the sum of the four major PS (sitosterol, campesterol, brassicaterol and stigmasterol) in subjects with low vs. high plasma sitosterol þ campesterol/TC at baseline, but also without a significant treatment by group interaction.</s><s>Only the TCstandardized increases in sitosterol and the sum of the four major PS were borderline significantly different between low and high absorbers, but this effect is likely inflated by the expected reduction in total cholesterol with PS intake.</s><s>Nevertheless, our data do not provide any indication that PS are potentially hyperabsorbed by those with high basal cholesterol absorption rates.</s></p><p><s>Our study has several limitations that deserve mentioning.</s><s>First, our study was not specifically designed to investigate the impact of cholesterol metabolism efficiency on the cholesterol-lowering effect of PS like the study by MacKay et al. <ref type="bibr" target="#b10">[11]</ref>.</s><s>This study prospectively selected subjects with high or low TC-standardized lathosterol concentrations.</s><s>To be able to compare our findings with those of MacKay et al., we applied similar exclusion criteria to select our study population.</s><s>Second, our study was designed as a parallel study and not as a crossover study.</s><s>The subjects could therefore not serve as their own control.</s><s>As a compromise, we adjusted our analysis for the concentrations at baseline.</s></p><p><s>In conclusion, increases in plasma PS and reductions in total-and LDL-cholesterol concentrations clearly stabilized within the first four weeks of PS intervention.</s><s>The increases in plasma PS were not significantly impacted by basal cholesterol synthesis or absorption efficiency.</s><s>Furthermore, we could not confirm an enhanced cholesterol-lowering effect of PS intake in low vs. high cholesterol synthesizers or in high vs. low cholesterol absorbers as observed in some other studies.</s><s>More studies, specifically designed to investigate this matter, are needed to be able to elucidate sources of heterogeneity in responsiveness to PS treatment.</s><s>measurement of plasma plant sterols.</s><s>RTR, WPK, UG, AOH, DF and EAT are employed by Unilever R&amp;D Vlaardingen, the Netherlands; Unilever markets food products enriched with plant sterols.</s><s>Funding for the current study was provided by Unilever.</s><s>RTR, WPK, UG, and EAT designed research, WPK and FW conducted research, AOH, UG and RTR performed statistical analysis, RTR, DF, UG and EAT interpreted the data; RTR wrote paper, and RTR and EAT had primary responsibility for final content.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 Plasma sitosterol (A) and campesterol (B), serum total cholesterol (C) and LDL-cholesterol (D) concentrations during 12 weeks of intervention with a low-fat spread with added plant sterols.</s><s>The sitosterol and campesterol data are based on a subset of 95 subjects for which we had non-cholesterol sterol data at repeated time points.</s><s>Results are expressed as means and 95%CI.</s><s>P-values of the interaction between treatment and visit are shown based on the analyses with log-transformed data for plasma sitosterol or campesterol.</s></p></div></figDesc><graphic coords="4,108.62,473.22,369.83,214.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Explorative analysis showing placebo-corrected changes from baseline in LDL-cholesterol (A) and in the sum of the four major plasma plant sterols (sitosterol, campesterol, brassicasterol and stigmasterol; B) for groups of low and high cholesterol synthesis (defined by the baseline lathosterol/TC ratio) and absorption (defined by the baseline sitosterol þ campesterol/TC ratio), separately for women and men.</s><s>Results are expressed as Least squares means and 95%CI.</s></p></div></figDesc><graphic coords="7,59.92,56.69,226.77,239.30" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Subject characteristics.</s></p></div></figDesc><table><row><cell></cell><cell>All subjects</cell><cell cols="2">Cholesterol synthesis a</cell><cell cols="2">Cholesterol absorption a</cell></row><row><cell></cell><cell>(n Z 240)</cell><cell>Low</cell><cell>High</cell><cell>Low</cell><cell>High</cell></row><row><cell></cell><cell></cell><cell>(n Z 59 b )</cell><cell>(n Z 59)</cell><cell>(n Z 59)</cell><cell>(n Z 59)</cell></row><row><cell>Gender, f/m</cell><cell>90/150</cell><cell>22/37</cell><cell>22/37</cell><cell>22/37</cell><cell>22/37</cell></row><row><cell>Age, year</cell><cell>53.2 AE 6.8</cell><cell>53.2 AE 6.8</cell><cell>53.2 AE 6.8</cell><cell>55.1 AE 6.7</cell><cell>53.1 AE 6.7</cell></row><row><cell>Weight, kg</cell><cell>77.7 AE 13.0</cell><cell>73.1 AE 12.5</cell><cell>80.1 AE 11.5</cell><cell>79.7 AE 13.1</cell><cell>75.7 AE 12.6</cell></row><row><cell>BMI, kg/m 2</cell><cell>25.3 AE 2.8</cell><cell>23.8 AE 2.8</cell><cell>26.1 AE 2.5</cell><cell>26.2 AE 2.7</cell><cell>24.5 AE 2.8</cell></row><row><cell>Total cholesterol, mmol/L</cell><cell>5.75 AE 0.94</cell><cell>5.84 AE 0.88</cell><cell>5.48 AE 0.92</cell><cell>5.75 AE 0.97</cell><cell>5.76 AE 0.83</cell></row><row><cell>LDL-cholesterol, mmol/L</cell><cell>3.90 AE 0.63</cell><cell>3.93 AE 0.63</cell><cell>3.80 AE 0.57</cell><cell>3.90 AE 0.62</cell><cell>3.87 AE 0.58</cell></row><row><cell>HDL-cholesterol, mmol/L</cell><cell>1.38 AE 0.43</cell><cell>1.52 AE 0.41</cell><cell>1.22 AE 0.41</cell><cell>1.33 AE 0.44</cell><cell>1.49 AE 0.41</cell></row><row><cell>Triglycerides, mmol/L</cell><cell>1.07 [0.77; 1.44]</cell><cell>0.91 [0.72; 1.18]</cell><cell>1.20 [0.86; 1.73]</cell><cell>1.22 [0.83; 1.74]</cell><cell>0.85 [0.71; 1.22]</cell></row><row><cell>Sitosterol, mmol/L</cell><cell>6.36 [4.62; 7.92]</cell><cell>7.49 [6.45; 9.97]</cell><cell>4.46 [3.68; 6.36]</cell><cell>3.93 [3.35; 4.70]</cell><cell>9.37 [7.69; 11.07]</cell></row><row><cell cols="2">Sitosterol/TC 38; 2.35]</cell><cell>2.13 [1.69; 2.88]</cell><cell>1.44 [1.06; 1.89]</cell><cell>1.07 [0.89; 1.23]</cell><cell>2.83 [2.42; 3.18]</cell></row><row><cell>Brassicasterol, mmol/L</cell><cell>0.72 [0.48; 1.03]</cell><cell>0.89 [0.56; 1.18]</cell><cell>0.60 [0.37; 0.95]</cell><cell>0.36 [0.24; 0.56]</cell><cell>1.17 [0.91; 1.54]</cell></row><row><cell cols="2">Brassicasterol/TC, mmol/mmol 0.13 [0.08; 0.19]</cell><cell>0.15 [0.09; 0.21]</cell><cell>0.10 [0.07; 0.17]</cell><cell>0.06 [0.04; 0.09]</cell><cell>0.21 [0.16; 0.26]</cell></row><row><cell>Stigmasterol, mmol/L</cell><cell>0.39 [0.28; 0.60]</cell><cell>0.43 [0.32; 0.62]</cell><cell>0.39 [0.28; 0.60]</cell><cell>0.30 [0.22; 0.47]</cell><cell>0.39 [0.28; 0.56]</cell></row><row><cell cols="2">Stigmasterol/TC, mmol/mmol 0.07 [0.05; 0.10]</cell><cell>0.08 [0.06; 0.11]</cell><cell>0.07 [0.04; 0.11]</cell><cell>0.05 [0.04; 0.09]</cell><cell>0.07 [0.05; 0.10]</cell></row><row><cell>Plant sterols, mmol/L</cell><cell cols="5">17.92 [13.78; 22.46] 21.69 [18.18; 28.68] 13.82 [10.43; 18.37] 10.62 [9.46; 12.86] 27.02 [22.26; 33.18]</cell></row><row><cell cols="2">Plant sterols/TC, mmol/mmol 3.09 [2.40; 3.89]</cell><cell>3.85 [3.08; 4.76]</cell><cell>2.55 [1.92; 3.23]</cell><cell>1.96 [1.66; 2.20]</cell><cell>4.70 [4.22; 5.41]</cell></row><row><cell>Lathosterol, mmol/L</cell><cell>7.14 [5.35; 8.99]</cell><cell>4.65 [4.05; 5.48]</cell><cell>9.94 [8.38; 11.34]</cell><cell cols="2">8.39 [6.77; 10.91] 5.51 [4.37; 7.44]</cell></row><row><cell>Lathosterol/TC, mmol/mmol</cell><cell>1.23 [0.92; 1.56]</cell><cell>0.84 [0.65; 0.98]</cell><cell>1.80 [1.40; 2.07]</cell><cell>1.47 [1.22; 1.84]</cell><cell>1.00 [0.77; 1.24]</cell></row><row><cell>Desmosterol, mmol/L</cell><cell>4.21 [3.38; 5.09]</cell><cell>3.53 [2.77; 3.86]</cell><cell>4.71 [3.79; 5.46]</cell><cell>4.75 [3.67; 5.62]</cell><cell>3.69 [2.83; 4.54]</cell></row><row><cell cols="2">Desmosterol/TC, mmol/mmol 0.72 [0.59; 0.86]</cell><cell>0.60 [0.48; 0.69]</cell><cell>0.81 [0.70; 0.97]</cell><cell>0.82 [0.67; 0.96]</cell><cell>0.66 [0.53; 0.81]</cell></row><row><cell>Sitostanol, mmol/L</cell><cell>1.37 [0.99; 1.78]</cell><cell>1.66 [1.40; 2.10]</cell><cell>1.00 [0.74; 1.47]</cell><cell>0.85 [0.61; 1.19]</cell><cell>1.95 [1.62; 2.37]</cell></row><row><cell>Sitostanol/TC, mmol/mmol</cell><cell>0.23 [0.17; 0.30]</cell><cell>0.29 [0.24; 0.39]</cell><cell>0.18 [0.15; 0.25]</cell><cell>0.16 [0.11; 0.21]</cell><cell>0.35 [0.30; 0.41]</cell></row><row><cell>Campestanol, mmol/L</cell><cell>0.55 [0.38; 0.85]</cell><cell>0.53 [0.39; 0.84]</cell><cell>0.56 [0.38; 0.93]</cell><cell>0.46 [0.37; 0.85]</cell><cell>0.52 [0.41; 0.65]</cell></row><row><cell cols="2">Campestanol/TC, mmol/mmol 0.09 [0.07; 0.14]</cell><cell>0.10 [0.07; 0.14]</cell><cell>0.09 [0.07; 0.15]</cell><cell>0.09 [0.06; 0.12]</cell><cell>0.09 [0.07; 0.12]</cell></row></table><note><p><s>c , mmol/mmol 1.09 [0.83; 1.33] 1.29 [1.13; 1.61] 0.83 [0.67; 1.13] 0.70 [0.57; 0.82] 1.58 [1.44; 1.93] Campesterol, mmol/L 10.53 [7.82; 13.53] 12.48 [9.96; 17.27] 7.85 [5.67; 10.39] 5.98 [5.19; 7.12] 16.15 [13.49; 19.77] Campesterol/TC, mmol/mmol 1.77 [1.Values are expressed as mean AE SD or, in case of not normally distributed data, as median [Q1; Q3].</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Changes in serum lipids and plasma non-cholesterol sterols in low and high cholesterol synthesizers after 12 weeks of plant sterol intake.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Change from baseline vs. placebo</cell><cell></cell><cell>P-value</cell><cell></cell><cell></cell></row><row><cell></cell><cell>All</cell><cell>Low synthesizers a</cell><cell>High synthesizers a</cell><cell cols="3">Treatment Group Treatment Â group</cell></row><row><cell></cell><cell>(n Z 108 b )</cell><cell>(n Z 53)</cell><cell>(n Z 55)</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">Total cholesterol, mmol/L À0.16 (À0.43; 0.12) À0.12 (À0.51; 0.28) À0.20 (À0.58; 0.19)</cell><cell>0.259</cell><cell>0.639</cell><cell>0.780</cell></row><row><cell>LDL-cholesterol, mmol/L</cell><cell cols="3">À0.19 (À0.39; 0.01) À0.19 (À0.47; 0.10) À0.20 (À0.47; 0.08)</cell><cell>0.057</cell><cell>0.235</cell><cell>0.970</cell></row><row><cell>HDL-cholesterol, mmol/L</cell><cell>0.04 (À0.04; 0.11)</cell><cell>0.08 (À0.02; 0.19)</cell><cell>À0.01 (À0.11; 0.10)</cell><cell>0.304</cell><cell>0.957</cell><cell>0.242</cell></row><row><cell>Triglycerides c , %</cell><cell>1.9 (À8.8; 13.9)</cell><cell>2.1 (À13.0; 19.8)</cell><cell>1.7 (À12.9; 18.7)</cell><cell>0.738</cell><cell>0.514</cell><cell>0.973</cell></row><row><cell>Sitosterol, %</cell><cell>86.8 (65.8; 110.5)</cell><cell>70.1 (43.8; 101.4)</cell><cell>105.1 (73.7; 142.3)</cell><cell>&lt;0.001</cell><cell>0.296</cell><cell>0.118</cell></row><row><cell>Sitosterol/TC d , %</cell><cell>97.7 (74.8; 123.7)</cell><cell>79.9 (51.1; 114.1)</cell><cell>117.3 (83.0; 158.1)</cell><cell>&lt;0.001</cell><cell>0.379</cell><cell>0.125</cell></row><row><cell>Campesterol, %</cell><cell>36.7 (24.4; 50.2)</cell><cell>35.1 (18.3; 54.1)</cell><cell>38.3 (21.4; 57.7)</cell><cell>&lt;0.001</cell><cell>0.519</cell><cell>0.795</cell></row><row><cell>Campesterol/TC, %</cell><cell>43.5 (31.8; 56.4)</cell><cell>41.7 (25.7; 59.8)</cell><cell>45.4 (29.1; 63.7)</cell><cell>&lt;0.001</cell><cell>0.560</cell><cell>0.765</cell></row><row><cell>Brassicasterol, %</cell><cell>55.8 (27.0; 91.2)</cell><cell>47.3 (10.2; 96.9)</cell><cell>64.9 (24.2; 118.9)</cell><cell>&lt;0.001</cell><cell>0.699</cell><cell>0.579</cell></row><row><cell>Brassicasterol/TC, %</cell><cell>63.9 (33.4; 101.4)</cell><cell>54.0 (15.0; 106.3)</cell><cell>74.5 (31.3; 132.0)</cell><cell>&lt;0.001</cell><cell>0.708</cell><cell>0.541</cell></row><row><cell>Stigmasterol, %</cell><cell>À20.6 (À38.5; 2.6)</cell><cell>À25.8 (À48.9; 7.8)</cell><cell>À15.0 (À40.6; 21.5)</cell><cell>0.077</cell><cell>0.940</cell><cell>0.607</cell></row><row><cell>Stigmasterol/TC, %</cell><cell>À15.8 (À34.7; 8.7)</cell><cell cols="2">À20.6 (À45.2; 15.0) À10.6 (À37.3; 27.5)</cell><cell>0.184</cell><cell>0.864</cell><cell>0.650</cell></row><row><cell>Plant sterols e , %</cell><cell>53.9 (38.6; 70.8)</cell><cell>45.5 (25.6; 68.5)</cell><cell>62.7 (40.9; 88.0)</cell><cell>&lt;0.001</cell><cell>0.868</cell><cell>0.276</cell></row><row><cell>Plant sterols/TC, %</cell><cell>62.4 (46.2; 80.4)</cell><cell>53.3 (32.3; 77.7)</cell><cell>72.1 (48.9; 98.8)</cell><cell>&lt;0.001</cell><cell>0.846</cell><cell>0.263</cell></row><row><cell>Lathosterol, %</cell><cell>10.9 (0.8; 22.1)</cell><cell>11.8 (À2.6; 28.3)</cell><cell>10.1 (À3.7; 25.9)</cell><cell>0.034</cell><cell>0.399</cell><cell>0.876</cell></row><row><cell>Lathosterol/TC, %</cell><cell>18.1 (7.9; 29.2)</cell><cell>19.6 (5.0; 36.2)</cell><cell>16.5 (2.7; 32.2)</cell><cell>&lt;0.001</cell><cell>0.721</cell><cell>0.779</cell></row><row><cell>Desmosterol, %</cell><cell>2.0 (À6.7; 11.5)</cell><cell>À1.6 (À13.5; 11.8)</cell><cell>5.8 (À6.6; 19.8)</cell><cell>0.656</cell><cell>0.434</cell><cell>0.422</cell></row><row><cell>Desmosterol/TC, %</cell><cell>8.3 (0.0; 17.2)</cell><cell>4.9 (À6.5; 17.7)</cell><cell>11.7 (0.0; 24.9)</cell><cell>0.051</cell><cell>0.886</cell><cell>0.439</cell></row><row><cell>Sitostanol, %</cell><cell>À5.5 (À17.1; 7.8)</cell><cell>À15.5 (À29.9; 1.9)</cell><cell>5.7 (À12.1; 27.1)</cell><cell>0.396</cell><cell>0.581</cell><cell>0.094</cell></row><row><cell>Sitostanol/TC, %</cell><cell>0.2 (À12.1; 14.2)</cell><cell>À10.4 (À25.6; 7.9)</cell><cell>12.0 (À6.8; 34.6)</cell><cell>0.980</cell><cell>0.656</cell><cell>0.093</cell></row><row><cell>Campestanol, %</cell><cell>À9.2 (À27.7; 14.2)</cell><cell cols="2">À15.6 (À39.2; 17.4) À2.3 (À29.0; 34.5)</cell><cell>0.407</cell><cell>0.455</cell><cell>0.530</cell></row><row><cell>Campestanol/TC, %</cell><cell>À3.8 (À22.8; 19.9)</cell><cell cols="2">À10.5 (À34.8; 22.8) 3.5 (À23.9; 40.7)</cell><cell>0.729</cell><cell>0.431</cell><cell>0.517</cell></row></table><note><p><s>a High or low cholesterol synthesizers were defined using the gender-specific 25th and 75th percentiles of the basal lathosterol/TC ratio as cutoffs.b</s><s>This n is the maximal number of subjects that has been included to analyze the variables listed; per variable, a few missings may have been present.</s><s>c In case of not normally distributed data (all non-cholesterol sterols and triglycerides), analysis was performed based on log transformed values and results are expressed in % change from baseline vs. placebo.</s><s>d Non-cholesterol sterols were standardized by using the total cholesterol (TC) value from the same GC-MS assay.</s><s>e Plant sterols is the sum of sitosterol, campesterol, brassicasterol and stigmasterol.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Changes in serum lipids and plasma non-cholesterol sterols in low and high cholesterol absorbers after 12 weeks of plant sterol intake.High or low cholesterol absorbers were defined using the gender-specific 25th and 75th percentiles of the basal sitosterol þ campesterol/TC ratio as cut-offs.b</s><s>This n is the maximal number of subjects that has been included to analyze the variables listed; per variable, a few missings may have been present.</s><s>c In case of not normally distributed data (all non-cholesterol sterols and triglycerides), analysis was performed based on log transformed values and results are expressed in % change from baseline vs. placebo.</s><s>d Non-cholesterol sterols were standardized by using the total cholesterol (TC) value from the same GC-MS assay.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Change from baseline vs. placebo</cell><cell></cell><cell>P-value</cell><cell></cell><cell></cell></row><row><cell></cell><cell>All</cell><cell>Low absorbers a</cell><cell>High absorbers a</cell><cell cols="3">Treatment Group Treatment Â group</cell></row><row><cell></cell><cell>(n Z 108 b )</cell><cell>(n Z 54)</cell><cell>(n Z 54)</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">Total cholesterol, mmol/L À0.20 (À0.50; 0.11) À0.18 (À0.60; 0.25) À0.22 (À0.66; 0.23)</cell><cell>0.209</cell><cell>0.466</cell><cell>0.903</cell></row><row><cell>LDL-cholesterol, mmol/L</cell><cell cols="3">À0.19 (À0.41; 0.02) À0.15 (À0.45; 0.15) À0.23 (À0.55; 0.08)</cell><cell>0.080</cell><cell>0.538</cell><cell>0.712</cell></row><row><cell>HDL-cholesterol, mmol/L</cell><cell>0.03 (À0.06; 0.11)</cell><cell cols="2">À0.01 (À0.13; 0.11) 0.06 (À0.07; 0.18)</cell><cell>0.567</cell><cell>0.965</cell><cell>0.490</cell></row><row><cell>Triglycerides c , %</cell><cell>À5.3 (À17.0; 8.1)</cell><cell>À5.0 (À20.9; 14.1)</cell><cell>À5.5 (À21.9; 14.3)</cell><cell>0.419</cell><cell>0.840</cell><cell>0.964</cell></row><row><cell>Sitosterol, %</cell><cell>80.7 (59.3; 105.1)</cell><cell>100.3 (68.0; 138.7)</cell><cell>63.1 (35.9; 95.7)</cell><cell>&lt;0.001</cell><cell>0.561</cell><cell>0.111</cell></row><row><cell>Sitosterol/TC d , %</cell><cell>92.8 (68.5; 120.6)</cell><cell>120.3 (82.7; 165.6)</cell><cell>68.7 (38.9; 104.8)</cell><cell>&lt;0.001</cell><cell>0.905</cell><cell>0.052</cell></row><row><cell>Campesterol, %</cell><cell>29.6 (17.5; 43.1)</cell><cell>34.2 (17.0; 53.9)</cell><cell>25.3 (8.7; 44.3)</cell><cell>&lt;0.001</cell><cell>0.018</cell><cell>0.489</cell></row><row><cell>Campesterol/TC, %</cell><cell>37.9 (25.4; 51.5)</cell><cell>47.0 (29.0; 67.6)</cell><cell>29.3 (12.9; 48.0)</cell><cell>&lt;0.001</cell><cell>0.525</cell><cell>0.177</cell></row><row><cell>Brassicasterol, %</cell><cell>33.0 (7.6; 64.5)</cell><cell>34.8 (0.1; 81.6)</cell><cell>31.2 (À3.3; 78.0)</cell><cell>0.009</cell><cell>0.003</cell><cell>0.899</cell></row><row><cell>Brassicasterol/TC, %</cell><cell>42.1 (14.8; 76.1)</cell><cell>49.7 (10.9; 102.0)</cell><cell>35.0 (À0.7; 83.6)</cell><cell>0.002</cell><cell>0.007</cell><cell>0.635</cell></row><row><cell>Stigmasterol, %</cell><cell>À21.5 (À39.3; 1.5)</cell><cell>À26.0 (À48.0; 5.4)</cell><cell>À16.8 (À42.4; 20.2)</cell><cell>0.064</cell><cell>0.072</cell><cell>0.648</cell></row><row><cell>Stigmasterol/TC, %</cell><cell>À16.4 (À35.2; 7.8)</cell><cell cols="2">À14.0 (À40.2; 23.8) À18.8 (À42.7; 15.2)</cell><cell>0.165</cell><cell>0.065</cell><cell>0.821</cell></row><row><cell>Plant sterols e , %</cell><cell>48.3 (32.7; 65.8)</cell><cell>60.8 (37.3; 88.3)</cell><cell>36.8 (16.9; 60.1)</cell><cell>&lt;0.001</cell><cell>0.285</cell><cell>0.152</cell></row><row><cell>Plant sterols/TC, %</cell><cell>58.5 (41.4; 77.6)</cell><cell>78.3 (51.7; 109.5)</cell><cell>40.8 (19.9; 65.5)</cell><cell>&lt;0.001</cell><cell>0.765</cell><cell>0.043</cell></row><row><cell>Lathosterol, %</cell><cell>9.0 (À3.4; 22.9)</cell><cell>0.0 (À15.2; 17.9)</cell><cell>18.7 (À0.4; 41.5)</cell><cell>0.160</cell><cell>0.663</cell><cell>0.159</cell></row><row><cell>Lathosterol/TC, %</cell><cell>16.1 (3.8; 29.8)</cell><cell>9.3 (À6.2; 27.4)</cell><cell>23.2 (4.6; 45.1)</cell><cell>0.010</cell><cell>0.893</cell><cell>0.292</cell></row><row><cell>Desmosterol, %</cell><cell>1.3 (À8.2; 11.9)</cell><cell>À6.8 (À18.7; 6.9)</cell><cell>10.1 (À4.7; 27.3)</cell><cell>0.795</cell><cell>0.099</cell><cell>0.100</cell></row><row><cell>Desmosterol/TC, %</cell><cell>7.7 (À1.5; 17.9)</cell><cell>1.0 (À10.8; 14.4)</cell><cell>15.0 (0.8; 31.1)</cell><cell>0.103</cell><cell>0.113</cell><cell>0.161</cell></row><row><cell>Sitostanol, %</cell><cell>À9.3 (À20.9; 4.0)</cell><cell>À5.9 (À22.2; 13.8)</cell><cell>À12.6 (À28.3; 6.4)</cell><cell>0.159</cell><cell>0.129</cell><cell>0.593</cell></row><row><cell>Sitostanol/TC, %</cell><cell>À3.0 (À15.6; 11.4)</cell><cell>3.9 (À14.3; 25.9)</cell><cell>À9.5 (À25.9; 10.5)</cell><cell>0.660</cell><cell>0.306</cell><cell>0.327</cell></row><row><cell>Campestanol, %</cell><cell>À18.0 (À35.4; 4.0)</cell><cell>À23.0 (À44.4; 6.7)</cell><cell>À12.8 (À38.1; 23.0)</cell><cell>0.101</cell><cell>0.146</cell><cell>0.600</cell></row><row><cell>Campestanol/TC, %</cell><cell>À12.8 (À30.8; 9.7)</cell><cell cols="2">À15.3 (À38.1; 16.0) À10.3 (À35.7; 25.0)</cell><cell>0.238</cell><cell>0.118</cell><cell>0.805</cell></row></table><note><p><s>a e Plant sterols is the sum of sitosterol, campesterol, brassicasterol and stigmasterol.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Plasma plant sterols and cholesterol metabolism</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We would like to acknowledge A. Schulz and A. Hüser for coordination of the study, J. Sterken as the monitor for the study, S. Verduyn for production of the test products, J. Schilt for data management and M. Popering for</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Katan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Grundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Miettinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Paoletti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="965" to="e78" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Ras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Geleijnse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="214" to="e219" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American heart association task force on practice guidelines</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Lichtenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bairey</forename><surname>Merz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Blum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Eckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="S1" to="e45" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Reiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Catapano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Backer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Taskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Wiklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1769" to="e818" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Role of plant sterols in cholesterol lowering</title>
		<author>
			<persName><forename type="first">L</forename><surname>Normen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Frohlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trautwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Phytosterols as functional foods components and nutraceuticals</title>
				<editor>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Dutta</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="page" from="243" to="e315" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Proposed mechanisms of cholesterollowering action of plant sterols</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gsmj</forename><surname>Duchateau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><surname>Sm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hof</forename><surname>Molhuizen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Ntanios</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Lipid Sci Technol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="171" to="e85" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present</title>
		<author>
			<persName><forename type="first">E</forename><surname>De Smet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mensink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Plat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Nutr Food Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="1058" to="1e72" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Gastrointestinal absorption and plasma kinetics of soy delta(5)-phytosterols and phytostanols in humans</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Ostlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mcgill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Covey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stearns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Stenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="E911" to="e916" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Varady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trautwein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mensink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Plat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Rev</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="385" to="e402" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrationsea meta-analysis of randomized controlled studies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Ras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hiemstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Duchateau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">230</biblScope>
			<biblScope unit="page" from="336" to="e346" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Lathosterol-tocholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, singleblind placebo-controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Gebauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Eck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="432" to="e439" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The effect of a low-fat spread with added plant sterols on vascular function markers: results of the investigating vascular function effects of plant sterols (INVEST) study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Ras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Koppenol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Garczarek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Greyling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Keicher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="733" to="e741" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Clifton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Noakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fassoulakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cehun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nestel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1493" to="e1499" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Houweling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Vanstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Duchateau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="543" to="e51" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Phytosterols in cardiovascular disease: innocuous dietary components, or accelerators of atherosclerosis?</title>
		<author>
			<persName><forename type="first">W</forename><surname>Jessup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Herman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Chapman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Lipidol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="301" to="e310" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Plant sterols and cardiovascular disease: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Genser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Silbernagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Backer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bruckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Carmena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="444" to="e51" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Kris-Etherton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dietschy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1590S" to="e1596" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Cholesterollowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Bergmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Croghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="1198" to="e206" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol estercontaining spread to statin therapy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Capuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">B</forename><surname>Cater</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="46" to="e52" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Effects of phytosterol ester-enriched vegetable oil on plasma lipoproteins in healthy men</title>
		<author>
			<persName><forename type="first">S</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hidaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Aoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okazaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asia Pac J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="282" to="e91" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Effects of dietary diacylglycerol oil containing phytosterols in mayonnaise on abdominal fat and blood cholesterol levels in Japanese men</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takeshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moriwaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shiba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jpn Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="973" to="e87" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Safety of long-term consumption of plant sterol esters-enriched spread</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Hendriks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Princen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Ntanios</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="681" to="e92" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment</title>
		<author>
			<persName><forename type="first">A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Plat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lutjohann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Mensink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="937" to="e941" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Santosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Varady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abumweis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="505" to="e514" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Rideout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Abumweis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="41" to="e46" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Effects of plant sterol esters in skimmed milk and vegetable-fat-enriched milk on serum lipids and noncholesterol sterols in hypercholesterolaemic subjects: a randomised, placebo-controlled, crossover study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Casas-Agustench</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Serra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Perez-Heras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cofan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Trautwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="1766" to="1e75" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hernandez-Mijares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Banuls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bellod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Martinez-Triguero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="604" to="e609" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takeshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Katsuragi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kusuhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Higashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Miyajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mizuno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Metab Cardiovasc Dis</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="483" to="e91" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mussner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Parhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Bergmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schwandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Broedl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="189" to="e94" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
